drugset / Trial / NCT03563235

Clinical Study on Treatment of Postmenopausal Osteoporosis (Kidney Deficiency and Blood Stasis Syndrome) With Xulin Jiangu Granules

NCT03563235

RandomizedParallel-groupDouble-blindTreatment

Summary

Osteoporosis is a common senile disease with a high incidence. The Chinese medicine differentiation treatment has small side effects and can be taken for a long time, which has certain advantages. This project adopts the experience of the person in charge of the project-Xulin Jiangu Granules and clinically collects patients with postmenopausal osteoporosis (kidney deficiency and blood stasis syndrome).

Timeline

Start
2019-09-01
Primary completion
2021-09-30
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 0.25 ug Oral
Subject Xulin Jiangu granules Unknown 15 g Oral